These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28921528)

  • 1. Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities.
    Bruni O; Angriman M; Calisti F; Comandini A; Esposito G; Cortese S; Ferri R
    J Child Psychol Psychiatry; 2018 May; 59(5):489-508. PubMed ID: 28921528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders.
    Bruni O; Angriman M; Melegari MG; Ferri R
    Expert Opin Pharmacother; 2019 Dec; 20(18):2257-2271. PubMed ID: 31638842
    [No Abstract]   [Full Text] [Related]  

  • 3. Review of Safety and Efficacy of Sleep Medicines in Older Adults.
    Schroeck JL; Ford J; Conway EL; Kurtzhalts KE; Gee ME; Vollmer KA; Mergenhagen KA
    Clin Ther; 2016 Nov; 38(11):2340-2372. PubMed ID: 27751669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.
    Anand S; Tong H; Besag FMC; Chan EW; Cortese S; Wong ICK
    Paediatr Drugs; 2017 Jun; 19(3):235-250. PubMed ID: 28391425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review.
    Blackmer AB; Feinstein JA
    Pharmacotherapy; 2016 Jan; 36(1):84-98. PubMed ID: 26799351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
    Abad VC; Guilleminault C
    Drugs Aging; 2018 Sep; 35(9):791-817. PubMed ID: 30058034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder.
    Bendz LM; Scates AC
    Ann Pharmacother; 2010 Jan; 44(1):185-91. PubMed ID: 20028959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder.
    Sangal RB; Blumer JL; Lankford DA; Grinnell TA; Huang H
    Pediatrics; 2014 Oct; 134(4):e1095-103. PubMed ID: 25266438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
    Rosenberg RP
    Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey.
    Owens JA; Rosen CL; Mindell JA; Kirchner HL
    Sleep Med; 2010 Aug; 11(7):692-700. PubMed ID: 20621556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chronic insomnia in elderly persons.
    Bain KT
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):168-92. PubMed ID: 16860264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Treatments for Sleep Disorders in Children: A Systematic Review.
    McDonagh MS; Holmes R; Hsu F
    J Child Neurol; 2019 Apr; 34(5):237-247. PubMed ID: 30674203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature.
    Hollway JA; Aman MG
    Res Dev Disabil; 2011; 32(3):939-62. PubMed ID: 21296553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review.
    Besterman AD; Jeste SS
    Eur Child Adolesc Psychiatry; 2023 Mar; 32(3):527-531. PubMed ID: 34611728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
    Sateia MJ; Buysse DJ; Krystal AD; Neubauer DN; Heald JL
    J Clin Sleep Med; 2017 Feb; 13(2):307-349. PubMed ID: 27998379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians.
    Owens JA; Rosen CL; Mindell JA
    Pediatrics; 2003 May; 111(5 Pt 1):e628-35. PubMed ID: 12728122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
    Wilt TJ; MacDonald R; Brasure M; Olson CM; Carlyle M; Fuchs E; Khawaja IS; Diem S; Koffel E; Ouellette J; Butler M; Kane RL
    Ann Intern Med; 2016 Jul; 165(2):103-12. PubMed ID: 27136278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P; Nir T; Breddy J; Frydman-Marom A; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription Medications for the Treatment of Insomnia and Risk of Suicide Attempt: a Comparative Safety Study.
    Lavigne JE; Hur K; Kane C; Au A; Bishop TM; Pigeon WR
    J Gen Intern Med; 2019 Aug; 34(8):1554-1563. PubMed ID: 31161572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine-1 receptor antagonism for treatment of insomnia.
    Vande Griend JP; Anderson SL
    J Am Pharm Assoc (2003); 2012; 52(6):e210-9. PubMed ID: 23229983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.